MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/meg.0000000000002582

Медицинская библиотека · European journal of gastroenterology & hepatology · 2023

Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years.

Rigamonti Cristina, De Benedittis Carla, Labanca Sara, Vanni Ester, Morgando Anna, Manfredi Giulia Francesca, Azzolina Danila, Cittone Micol Giulia, Giannini Edoardo Giovanni, Saracco Giorgio Maria, Pirisi Mario

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Primary biliary cholangitis (PBC) is a rare chronic autoimmune cholangiopathy, characterized by a variable course and response to treatment. We aimed to describe long-term outcomes of PBC patients referred to three academic centres in Northwest Italy.

METHODS

This is an ambispective cohort study of PBC patients (retrospective component: diagnosis before 1 January 2019; prospective component: thereafter), including 302 patients: 101 (33%) followed up in Novara, 86 (28%) in Turin, 115 (38%) in Genoa. Clinical features at diagnosis, biochemical response to therapy and survival were analyzed.

RESULTS

Among the 302 patients (88% women, median age 55 years, median follow-up 75 months), alkaline phosphatase (ALP) levels significantly decreased during treatment with ursodeoxycholic acid (UDCA, P < 0.0001) and obeticholic acid (P < 0.0001). At multivariate analysis, ALP at diagnosis was predictive of 1-year biochemical response to UDCA [odds ratio 3.57, 95% confidence interval (CI) 1.4-9, P < 0.001]. Estimated median survival free of liver transplantation and hepatic complications was 30 years (95% CI 19-41). Bilirubin level at diagnosis was the only independent risk factor for the combined outcome of death, transplantation or hepatic decompensation (hazard ratio, 1.65, 95% CI 1.66-2.56, P = 0.02). Patients presenting with total bilirubin at diagnosis ≥0.6 times the upper normal limit (ULN) had a significantly lower 10-year survival compared to those with bilirubin <0.6 times ULN (63% vs. 97%, P < 0.0001).

CONCLUSION

In PBC, both short-term response to UDCA and long-term survival can be predicted by simple conventional biomarkers of disease severity, obtained at diagnosis.

Для цитирования: Rigamonti Cristina, De Benedittis Carla, Labanca Sara, Vanni Ester, Morgando Anna, Manfredi Giulia Francesca, Azzolina Danila, Cittone Micol Giulia, Giannini Edoardo Giovanni, Saracco Giorgio Maria, Pirisi Mario. Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years.. European journal of gastroenterology & hepatology. 2023. DOI: 10.1097/meg.0000000000002582.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.